John Qiang Tan

Title: Innovations of John Qiang Tan

Introduction

John Qiang Tan is a notable inventor based in North Brunswick, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various diseases. With a total of three patents to his name, Tan's work is recognized for its potential impact on cancer treatment and other health disorders.

Latest Patents

Tan's latest patents include "Carbamate and urea compounds as multikinase inhibitors." This patent describes novel carbamate and urea compounds that serve as multikinase inhibitors, along with methods for their preparation. The pharmaceutical compositions derived from these compounds are aimed at treating cancer, infectious diseases, and other disorders associated with kinases. Another significant patent is "Cyclic compounds as immunomodulating agents," which details novel IDO inhibitors and their preparation methods. These pharmaceutical compositions are also intended for treating cancer, infectious diseases, and various other disorders.

Career Highlights

Tan is currently associated with Angex Pharmaceutical, Inc., where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a strong focus on creating effective treatments that can address critical health challenges.

Collaborations

Tan has collaborated with notable colleagues such as Wen-Lian Wu and Zhiqiang Yang, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

John Qiang Tan's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to advancing medical science. His work continues to pave the way for new treatments that can significantly improve patient outcomes.